Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
Log In
+44 (0) 203 086 8600 Call us on
All SectorsAerospaceAgriculture, Farming & Raw MaterialsAutomotive and PartsBusiness ServicesChemicalsConstruction
IndustrialInformation TechnologyLeisureLogisticsMediaPaper and PackagingPublishing and Printing
Real EstateRetailSecurityTelecommunicationsTextiles and ClothingTransportationTravel
Consumer GoodsDefenceEnergy and UtilitiesEnvironmentalFinance and BankingFood and DrinkHealthcare and Medical
Healthcare and Medical
Healthcare and Medical
Type
Keywords

Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.
Country
Industry Sector
Publisher
Order By
Published In
Advanced Search
Home >Market >Healthcare and Medical >Company Profile

Novagali Pharma SA - Product Pipeline Review - 2012

Report Overview
987.7

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£987.70
Add to Wishlist

Change Currency

 GBP EURO USD
Order By Fax

Market

 Healthcare and Medical

Report Type

 Company Profile

Country

 Global

Published

31 October 2012

Number of Pages

43

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

 Global Markets Direct

File Format

PDF

Novagali Pharma SA – Product Pipeline Review – 2012 - Global Market Direct's pharmaceuticals report, "Novagali Pharma SA - Product Pipeline Review - 2012" provides data on the Novagali Pharma SA's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from our proprietary databases, Novagali Pharma SA's corporate website, SEC filings, investor presentations and featured press releases, both from Novagali Pharma SA and industry-specific third party sources, put together by our team.

Scope

- Novagali Pharma SA - Brief Novagali Pharma SA overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Novagali Pharma SA human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Novagali Pharma SA with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Novagali Pharma SA's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Novagali Pharma SA's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Novagali Pharma SA in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Novagali Pharma SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Novagali Pharma SA.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Novagali Pharma SA and identify potential opportunities in those areas.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£987.70
Add to Wishlist

Change Currency

 GBP EURO USD

Visitor Comments

All Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
EURO
USD

Last Viewed

Novagali Pharma SA - Product Pipeline Review - 2012

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

News

US digestive remedies market to benefit from an unexpected surge in cases of norovirus

US ear care market led by Debrox with a 40% value share

Digital pathology market to reach a value of $542 million by 2018

Infectious disease treatments market driven by growth in middle-income to low-income countries

OCT imaging market led by Carl Zeiss and St. Jude Medical

Market Insights

Global Obesity Market

Global Medical Market Insight

ECG Devices Market

Czech Republic Veterinary Market Insight

Cardiovascular Devices Market

Latest News and Markets Insights

Companies And Markets

Home

Business News Team

About Us

Our Clients

Publishers

Become A Publisher

Become An Affiliate

Business News

Market Insights

Jobs

Contact Us

SiteMap

Customer Support

How to Purchase

Frequently Asked Questions

Register Now

Home

Customer Support Form

Pricing And Licenses

Email Alerts

Custom Research Services

Terms And Conditions

Our Report Types

Legals

Free Research Support

Corporate Accounts

Subscription Accounts

Competitor Tracking

eBrandPromote: Promote your Brand Online

Contact Details

Vertical Edge Limited
(www.companiesandmarkets.com)
Unit 6 (3rd floor) Tabernacle Court
16-28 Tabernacle Street
London, EC2A 4DD
United Kingdom

Email
enquiries@companiesandmarkets.com

Telephone
+44 (0) 203 086 8600

Accessibility
Close

Contrast settings

Text size settings